We responded to this study released last week, stating:
"Overall, FSC believes a fair position is one that balances the interests of consumers and the medical community to advance genetic science, and which manages financial risks to insurers and all policyholders."
Read more in this RNZ article.
We regularly review our stance and industry guidelines on genetic testing to ensure they reflect best practice globally.
Listen to the segment with Richard and Ingrid below to learn more: